Sartorius acquires WaterSep BioSeparations
Sartorius Stedim Biotech has acquired WaterSep BioSeparations for approximately $27 million plus an earn-out based on sales revenues through 2023 of up to $9 million. The transaction adds to Sartorius' filtration units for bioprocessing devices. Read More
FDA in final stages before issuing Pfizer, BioNTech EUA
The U.S. Food and Drug Administration (FDA) has informed Pfizer and BioNTech that it will work rapidly toward the finalization and issuance of an emergency use authorization (EUA) for the company's COVID-19 vaccine candidate. Read More
Moderna launches COVID-19 adolescent vaccine trial
Moderna has begun a late-stage trial for a COVID-19 vaccine for adolescents between 12 and 18 years of age. The vaccine is called messenger RNA (mRNA)-1273. Read More
Alligator launches new human antibody library
Alligator Bioscience has launched a new human antibody library in fragment antigen-binding format. Read More
Evaxion gets $24M from EIB for AI vaccine research
The European Investment Bank (EIB) has signed a loan for 20 million euros ($24.1 million U.S.) with Evaxion Biotech to support artificial intelligence (AI) vaccine research. Read More
Thermo Fisher expands manufacturing footprint
Thermo Fisher Scientific is expanding its footprint in North America and Europe in sterile drug product development and commercial manufacturing. Read More
Moderna to use Roche tests in COVID-19 vaccine trials
Moderna will use Roche's Elecsys anti-SARS-CoV-2 S antibody test in its messenger RNA (mRNA)-1273 vaccine research trials. The test can quantitatively measure the level of antibodies against SARS-CoV-2 in vaccine trial participants. Read More
Evaxion advances immune-oncology platform with new data
Evaxion Biotech has published data on the thermostability of peptide major histocompatibility complexes for antigen processing that will be used to improve neoepitope selection in the company's Pioneer platform. Read More
Health Canada approves emergency use for Pfizer, BioNTech's COVID-19 vaccine
Health Canada has granted authorization under an interim order for the emergency use of Pfizer-BioNTech's messenger RNA COVID-19 vaccine, BNT162b2. Read More
AiCure unveils data dashboards for clinical trials
Clinical trial artificial intelligence technology developer AiCure has introduced AiCure Data Intelligence, a data dashboard designed to enable clinical trial sponsors to track patient behavior and site performance. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
